PIEZO1 and liver cancer: The authors also indicated that inhibiting the activation of transforming growth factor β (TGF-β) signaling through Piezo1 reduces Rab5c recruitment, decreasing the proliferation and metastatic potential of liver cancer cells, diminishing their epithelial-mesenchymal transition capability, and making them more aggressive.